HAL vs KRYS · P/E 9.3, $19.05B cap vs P/E 46, rev $290.5M
Halliburton Company (HAL) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the HAL and KRYS stock pages for the full models.
Not investment advice.